Epilepsy Society has welcomed the findings of a new study which shows that the performance of the generic version of lamotrigine is equivalent to the original branded version of the the anti-epileptic medication.
Results of a Europe-wide review of the epilepsy drug valproate, known to cause birth defects, has resulted in the Government sending strengthened warnings to all prescribing doctors and pharmacists.
Researchers at Stanford University School of Medicine have found that a naturally occurring protein secreted only in discrete areas of the mammalian brain may act as a Valium-like brake on certain types of epileptic seizures.
Bright light therapy – commonly used to treat seasonal affective disorder – can reduce levels of depression and anxiety in patients with epilepsy, according to new research published online today by the British Journal of Psychiatry. Epilepsy Society’s consultant neuropsychologist Dr Sallie Baxendale was the lead researcher in the study of more than 100 patients with focal epilepsy not controlled by medication
We have been informed by Sanofi that there has been a temporary delay to the delivery of some medicines including Epilim and Frisium.
Our vision is for a world where epilepsy is irrelevant. And people with epilepsy lead the lives they want to lead. This year, following a major survey of people affected by epilepsy, we have become clearer in describing that Vision and setting out how we intend to make it happen.